Skip to main content
OpenTrials

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

9,049 public trials 1,774 recruiting studies
Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Completed

Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease

NCT00660673

Conditions
Advanced Parkinson's Disease, Basal Ganglia Diseases, Brain Diseases, +11 more
Locations
  • University of Alabama at Birmingham /ID# 49941 Birmingham, Alabama, United States
  • The Research Center of Southern California /ID# 49928 Encinitas, California, United States
  • The Parkinson's & Movement Disorder Institute - Fountain Valley /ID# 49915 Fountain Valley, California, United States
  • Universtiy of Southern California /ID# 49913 Los Angeles, California, United States
View all 61 locations
View Trial Details
Completed

Implementation of CAPABLE in the Michigan Medicaid Waiver

NCT03634033

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • Northeast Michigan Community Service Agency (NEMCSA) Alpena, Michigan, United States
  • Region 3B Area Agency on Aging/CareWell Services Southwest Battle Creek, Michigan, United States
  • Region VII Area Agency on Aging Bay City, Michigan, United States
  • Region 2 Area Agency on Aging Brooklyn, Michigan, United States
View all 18 locations
View Trial Details
Completed

Therapy in Amyotrophic Lateral Sclerosis (TAME)

NCT02118727

Conditions
Amyotrophic Lateral Sclerosis, Brain Diseases, Central Nervous System Diseases, +16 more
Locations
  • Phoenix Neurological Associates Phoenix, Arizona, United States
  • UC Irvine Irvine, California, United States
  • University of Florida Jacksonville, Florida, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
View all 13 locations
View Trial Details
Completed

Opicapone Treatment Initiation Open-Label Study

NCT04787965

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • Neurocrine clinical site Los Gatos, California, United States
  • Neurocrine clinical site Memphis, Tennessee, United States
  • Neurocrine clinical site Christiansburg, Virginia, United States
  • Neurocrine clinical site Norfolk, Virginia, United States
View Trial Details

Related conditions